drugset / Trial / NCT05098353
Seroquel ® in Patients With Bipolar Disorder in Remission With Signs of Impaired Impulse Control
Unknown
30 enrolled
Federal Stare Budgetary Scientific Institution, Mental Health Research Center
Federal State Budgetary Institution V.M. Bekhterev National Research Medical Center for Psychiatry and Neurology, Saint-Petersburg, Russia · collabKazan State Medical University · collab
NaSingle-groupOpen-labelTreatment
Summary
In this study, the task was to evaluate the effectiveness of prescribing small doses of quetiapine (25-75 mg) for bipolar patients in remission in order to relieve symptoms of impulsivity.
Timeline
- Start
- 2021-04-10
- Primary completion
- 2021-11-15
- Completion
- 2021-12-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Quetiapine | Small molecule | 25 mg | — |
| Subject | Quetiapine | Small molecule | 75 mg | — |